Select Board approves two tax-increment financing agreements worth combined $461K in exemptions.
Andover Select Board approves two major tax-increment financing agreements on a single vote. The board unanimously endorsed a $286,000 incremental tax exemption for AdvanCell, an Australian oncology pharmaceutical firm planning to locate its global headquarters at One Corporate Drive with a